BIOLASE To Participate In Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference

Rhea-AI Summary

BIOLASE, Inc. (NASDAQ: BIOL) announced that John Beaver, President and CEO, will present at Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference from March 17-19, 2021. Beaver will join a fireside chat with analyst Anthony Vendetti on March 17 from 10:30 am to 11:00 am Eastern Time. Investors can register for the conference here. BIOLASE specializes in laser systems for dental and medical applications, having sold over 41,200 systems worldwide.

FOOTHILL RANCH, Calif., March 16, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that John Beaver, President and Chief Executive Officer, is scheduled to present at Maxim Group's Inaugural 2021 Emerging Growth Virtual Investor Conference to be held March 17-19, 2021.

Mr. Beaver will participate in a fireside chat with Maxim analyst Anthony Vendetti on Wednesday, March 17^th from 10:30 am – 11:00 am Eastern Time (7:30 am – 8:00 am Pacific Time). To access the session, investors should register for the conference here. Following the conclusion of the conference, investors can also request a one-on-one meeting with BIOLASE management by contacting investor relations.

About BIOLASE, Inc.

BIOLASE is a medical device company that develops, manufactures, markets, and sells laser systems in dentistry and medicine. BIOLASE's products advance the practice of dentistry and medicine for patients and healthcare professionals. BIOLASE's proprietary laser products incorporate approximately 271 patented and 40 patent-pending technologies designed to provide biologically and clinically superior performance with less pain and faster recovery times. BIOLASE's innovative products provide cutting-edge technology at competitive prices to deliver superior results for dentists and patients. BIOLASE's principal products are revolutionary dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications.  BIOLASE has sold over 41,200 laser systems to date in over 80 countries around the world. Laser products under development address BIOLASE's core dental market and other adjacent medical and consumer applications.

For updates and information on Waterlase iPlus®, Waterlase Express™, and laser dentistry, find BIOLASE online at www.biolase.com, Facebook at www.facebook.com/biolase, Twitter at www.twitter.com/biolaseinc, Instagram at www.instagram.com/waterlase_laserdentistry, and LinkedIn at www.linkedin.com/company/biolase.

BIOLASE®, Waterlase® and Waterlase iPlus® are registered trademarks of BIOLASE, Inc.

 

View original content to download multimedia:http://www.prnewswire.com/news-releases/biolase-to-participate-in-maxim-groups-inaugural-2021-emerging-growth-virtual-investor-conference-301248103.html

SOURCE BIOLASE, Inc.

FAQ

What is the date for BIOLASE's presentation at the Maxim Group conference?

BIOLASE's presentation will take place on March 17, 2021.

Who will represent BIOLASE at the 2021 Emerging Growth Virtual Investor Conference?

John Beaver, President and CEO, will represent BIOLASE.

What time is BIOLASE's fireside chat during the conference?

The fireside chat is scheduled for 10:30 am to 11:00 am Eastern Time on March 17, 2021.

How can investors register for the BIOLASE conference session?

Investors can register for the conference by clicking here.

What products does BIOLASE focus on?

BIOLASE focuses on developing and selling laser systems for dentistry and medicine.